COMPANY

Alcamena Stem Cell Therapeutics

HQ: Baltimore, MD source · alcamenabio.com ↗

Alcamena Stem Cell Therapeutics is listed on ClinicalTrials.gov as the lead sponsor of 1 study; the most recently updated is “Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults” (Phase 1, recruiting), in Neuropathic Pain. Alcamena Stem Cell Therapeutics has received NIH funding, most recently in fiscal 2026 for the project “FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain”. From public records Source · Oct 12, 2026

Keywords: Cell Therapeutics ; Cell Therapeutics ; Peptide

Location: Halethorpe, MD · source · Oct 12, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1.5M (SBIR Phase II 5R44NS145934-02, continuation, notice Sep 4, 2026). NIH RePORTER 5R44NS145934-02 (Sep 4, 2026)
Evidence (1 event)
- Sep 4, 2026 · NIH RePORTER 5R44NS145934-02
  Organization: ALCAMENA STEM CELL THERAPEUTICS, LLC; City/State: Baltimore, MD; Project number: 5R44NS145934-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-04; FY total cost (award amount): 1500000; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Sep 4, 2026 Grant Government grant — SBIR: $1.5M (annual award, as published), announced Sep 4, 2026. Agency: NIH/NINDS. Source: government award database. source ↗
Sep 1, 2025 Grant Government grant: $2.55M (total, as published), announced Sep 1, 2025. Agency: DoD. Source: government award database. source ↗
Aug 7, 2025 Grant Government grant — SBIR: $1.5M (annual award, as published), announced Aug 7, 2025. Agency: NIH/NINDS. Source: government award database. source ↗

Funding

Last 2 years.

Sep 4, 2026 Government grant — SBIR: $1.5M (annual award, as published), announced Sep 4, 2026. Agency: NIH/NINDS. Source: government award database. source ↗
Sep 1, 2025 Government grant: $2.55M (total, as published), announced Sep 1, 2025. Agency: DoD. Source: government award database. source ↗
Aug 7, 2025 Government grant — SBIR: $1.5M (annual award, as published), announced Aug 7, 2025. Agency: NIH/NINDS. Source: government award database. source ↗